Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Advances in nanoparticles-based approaches in cancer theranostics
Oral GLP-1 agonist drug candidates overcome the limitation of injectable therapy by providing a more patient-friendly, painless and convenient alternative
The Science of Safety: Adverse Effects of GLP-1 Receptor Agonists as Glucose-Lowering and Obesity Medications
With this biotransformation, liver detoxification, a long-standing barrier in nanomedicine translation, can be turned into a bridge toward maximizing targeting and minimizing nanotoxicity
US$ 20.48
US$ 23.20
US$ 21.38
US$ 22.23
US$ 29.95
US$ 20.45
